Avoiding FDA Warning Letters: Why High Level Biodecontamination Is Essential in Pharma Manufacturing The FDA has issued warning letters to multiple companies marketing compounded Retatrutide, an investigational drug from Eli Lilly still in Phase II trials. While early studies have shown promising weight loss results, Retatrutide BPC 157 Capsules Vios Compounding The Human Lab Rats Injecting Themselves with Peptides Office for Science and Society McGill University